Welcome to the Vaccines and Immunizations website.
Skip directly to the search box, site navigation, or content.

Department of Health and Human Services
Centers for Disease Control and Prevention


Vaccines & Immunizations

Vaccines and Preventable Diseases:

Rotavirus Vaccination
Pronounced "row-tuh-virus"

Rotavirus is the leading cause of severe acute gastroenteritis (vomiting and severe diarrhea) among children worldwide. Two different rotavirus vaccines are currently licensed for use in infants in the United States. The vaccines are RotaTeq® (RV5) and Rotarix® (RV1). Before being licensed, both vaccines were tested in clinical trials and shown to be safe and effective. In these studies, during approximately the first year of an infant’s life, rotavirus vaccine was found to prevent almost all (85%-98%) rotavirus illness episodes that were severe and to prevent 74%-87% of all rotavirus illness episodes.

Rotavirus vaccination

For the Media:

What You Should Know

About the Disease

top of page

Vaccine Information
  • Does my child need the rotavirus vaccine?
    Yes! Rotavirus is the leading cause of severe acute gastroenteritis (vomiting and severe diarrhea) among children worldwide. Two different rotavirus vaccines are currently licensed for use in infants in the United States.
  • When does my child need the rotavirus vaccine?
    Your child should receive the vaccine during the first year infancy.
    There are two brands of rotavirus vaccine. A baby should get either 2 or 3 doses, depending on which brand is used.

    The doses are recommended at these ages:

    • First Dose: 2 months of age
    • Second Dose: 4 months of age
    • Third Dose: 6 months of age (if needed)

    The first dose may be given as early as 6 weeks of age, and should be given by age 14 weeks 6 days. The last dose should be given by 8 months of age.

    Rotavirus vaccine may be given at the same time as other childhood vaccines.

    Babies who get the vaccine may be fed normally afterward.

    For additional details, consult the Rotavirus Vaccine Information Statement Adobe Acrobat print-friendly PDF file.
    [PDF- 166KB, 2 pages] as well as the Child Immunization Schedule.

  • FDA: Information for Parents and Caregivers on Recommendation to Resume Use of Rotarix® and Continuing Use of RotaTeq®External Web Site Policy Updated May 2010
    In March 2010, FDA became aware of the presence PCV1 in Rotarix® and DNA from PCV1 and PCV2 in RotaTeq®. On May 14, 2010, the U.S. Food and Drug Administration revised its recommendations for rotavirus vaccines for the prevention of the disease in infants and has determined that it is appropriate for clinicians and healthcare professionals to resume the use of Rotarix® and to continue the use of RotaTeq®.
  • Questions and answers about rotavirus vaccines Updated Sep 2012
  • Side effects
  • Rotarix® Rotavirus Vaccine: Rare Side Effect Possible Posted Sep 2010
  • Vaccine Information Statement (VIS)

top of page

Vaccine Safety

As with all vaccines, there can be minor reactions, including pain and redness at the injection site, headache, fatigue or a vague feeling of discomfort.

top of page

Who Should Not be Vaccinated?

top of page

For Health Professionals

Clinical Information on Rotavirus

FDA Recommends Resuming Use of Rotarix® and Continuing Use of RotaTeq®
There are two licensed vaccines for rotavirus in the United States: RotaTeq® and Rotarix®. In March 2010, FDA became aware of the presence PCV1 in Rotarix® and DNA from PCV1 and PCV2 in RotaTeq®. These viruses are not known to cause any infection or illness in people. On May 14, 2010, the U.S. Food and Drug Administration revised its recommendations for rotavirus vaccines for the prevention of the disease in infants and has determined that it is appropriate for clinicians and healthcare professionals to resume the use of Rotarix® and to continue the use of RotaTeq®.

top of page

Vaccine Recommendations

top of page

References and Resources

top of page

Provider Education

top of page

Materials for Patients

top of page

For the Media

Materials for the Media

top of page

External Web Site Policy This symbol means you are leaving the CDC.gov Web site. For more information, please see CDC's Exit Notification and Disclaimer policy.

File Formats: All viewers, players, and plug-ins used on this site can be downloaded from the file formats page. (For example: Adobe Acrobat Reader for pdf files, Windows Media Player for audio and video files, PowerPoint Viewer for presentation slides, etc.)

This page last modified on September 14, 2012
Content last reviewed on April 22, 2011
Content Source: National Center for Immunization and Respiratory Diseases

Quick Links

Safer Healthier People

Centers for Disease Control and Prevention 1600 Clifton Rd, Atlanta, GA 30333, U.S.A
Public Inquiries: 1-800-CDC-INFO (232-4636); 1-888-232-6348 (TTY)

Vaccines and Immunizations